GT MOLECULAR, INC.

GT Molecular, Inc. specializes in the development, optimization, and validation of multi-pathogen molecular assays for public health surveillance systems. Their core capabilities center on advanced molecular diagnostics, including assay design, analytical validation, and laboratory implementation for wastewater-based epidemiology. The company leverages cutting-edge biotechnological methods to detect and quantify viral and bacterial pathogens in complex environmental matrices, supporting national monitoring initiatives. Technical expertise includes nucleic acid extraction, qPCR and multiplexed PCR platform optimization, bioinformatics integration, and quality control frameworks aligned with CDC and EPA guidelines. Their unique focus on scalable, high-throughput surveillance assays distinguishes them in the public health diagnostics space, particularly in non-traditional sample environments. GT Molecular maintains a strong, consistent relationship with the Department of Health and Human Services, delivering critical molecular testing and research services under national wastewater surveillance programs. Their work supports HHS’s public health emergency response infrastructure, with a demonstrated ability to transition research-stage assays into operational surveillance tools. This sustained engagement reflects a trusted partnership built on technical precision, regulatory alignment, and timely delivery for mission-critical public health outcomes. The contractor’s primary NAICS classifications—541380 (Testing Laboratories and Services) and 541714 (Research and Development in Biotechnology)—reflect a dual focus on applied laboratory validation and translational biotech innovation. They operate at the intersection of environmental health monitoring and molecular biology R&D, positioning themselves as a niche provider for government-funded pathogen detection systems. Their vertical specialization lies in wastewater-based pathogen surveillance, a rapidly growing domain within infectious disease preparedness. GT Molecular, Inc. is a small business structured as a 2L entity, headquartered in Fort Collins, Colorado. While currently without federal certifications, their technical proficiency and direct engagement with HHS programs demonstrate strong credibility in the federal biotech services market. Their geographic presence supports regional access to academic and public health laboratories, enhancing collaboration for field-deployable diagnostic solutions.